Survival by first-line treatment type and timing of progression among follicular lymphoma patients

Caroline Weibull
Additional contact information
Caroline Weibull: Karolinska Institutet

Northern European Stata Conference 2022 from Stata Users Group

Abstract: In follicular lymphoma (FL), progression of disease within 24 months has emerged as a popular prognostic marker for overall survival (OS). While it has considerable clinical relevance, there are also inherent limitations in relation to the

Date: 2022-10-12
References: Add references at CitEc
Citations:

Downloads: (external link)
http://repec.org/neur2022/Northern_Europe22_Weibull.pdf presentation materials (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:boc:neur22:03

Access Statistics for this paper

More papers in Northern European Stata Conference 2022 from Stata Users Group Contact information at EDIRC.
Bibliographic data for series maintained by Christopher F Baum ().